Now that the patents for Ocupress (carteolol) have expired, the medication is available in generic form. Generic Ocupress eye drops come in only one strength -- carteolol 1 percent ophthalmic solution. The generic version has been given an "AT" rating by the FDA, meaning it should be equivalent to the brand-name medicine.
Ocupress® (carteolol hydrochloride) is a prescription eye drop approved for the treatment of glaucoma and high eye pressure. It belongs to a group of medications known as beta blockers; it works to lower eye pressure by decreasing fluid production in the eye.
Brand-name Ocupress is manufactured by CIBA Vision Sterile Mfg. for Novartis Ophthalmics. However, the patents for Ocupress have expired, and this medication is currently available in generic form.
Generic Ocupress eye drops are available in one strength -- carteolol 1 percent ophthalmic solution. The medicine is made by a few different manufacturers, such as:
- Alcon Laboratories
- Bausch & Lomb Incorporated
- Falcon Pharmaceuticals, Ltd.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AT" rating means that the FDA has determined that a generic medication is equivalent to its brand-name counterpart. Generic carteolol has an "AT" rating, meaning it should be equivalent to Ocupress.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include preservatives or other ingredients that may cause problems for people with allergies or sensitivities.